Who we are
We are a true multidisciplinary society largely made up from the specialties of gynaecology, dermatology, genito-urinary medicine and pathology. Our membership consists of doctors and nurses and we work closely with allied health professionals aligned to vulval disease. This multidisciplinary approach to the speciality enables excellence in clinical outcomes and workforce training. We have a strong commitment to education and training working with our medical colleges striving to achieve high quality standards of care for patients. Our membership currently stands at 288 health professionals from a variety of different specialities.
The objectives of the society
Achievements include:
We are a true multidisciplinary society largely made up from the specialties of gynaecology, dermatology, genito-urinary medicine and pathology. Our membership consists of doctors and nurses and we work closely with allied health professionals aligned to vulval disease. This multidisciplinary approach to the speciality enables excellence in clinical outcomes and workforce training. We have a strong commitment to education and training working with our medical colleges striving to achieve high quality standards of care for patients. Our membership currently stands at 288 health professionals from a variety of different specialities.
The objectives of the society
- The relief of suffering for patients with vulval diseases
- The promotion of research into the cause and management of vulval diseases
- The practice, art and science of understanding, diagnosing and managing vulval diseases
Achievements include:
- Hosting clinical conferences. Our annual two-day meeting was held in Salisbury in April 2018 hosted by Dr Abi Kingston. It was an excellent conference and 146 delegates attended
- Guidelines on Vulval pain syndromes (published British Journal of Dermatology).
- Contribution to the NHS Clinical Knowledge on pruritus vulvae for primary care and first contact physicians.
- Completed a Cochrane review on lichen sclerosus treatment.
- Funding and clinically supporting the James Lind Alliance Priority Setting Partnership to identify and prioritise the top 10 future research questions for lichen sclerosus.
